IhnH. Eosinophilic fasciitis: from pathophysiology to treatment. Allergol Int. 2019;68(4):437-439. doi:10.1016/j.alit.2019.03.001
2.
MertensJSSeygerMMBThurlingsRMRadstakeTRDJde JongEMGJ. Morphea and eosinophilic fasciitis: an update. Am J Clin Dermatol. 2017;18(4):491-512. doi:10.1007/s40257-017-0269-x
3.
TognettiLMarroccoCCarraroA, et al. UVA-1 phototherapy as adjuvant treatment for eosinophilic fasciitis: in vitro and in vivo functional characterization. Int J Dermatol. 2022;61(6): 718-726. doi:10.1111/ijd.16003
4.
MaziluDBoltașiuLAMardaleDA, et al. Eosinophilic fasciitis: current and remaining challenges. Int J Mol Sci. 2023;24(3):1982. doi:10.3390/ijms24031982
5.
PehlDPreußeCAllenbachY, et al. Eosinophilic fasciitis (Shulman syndrome)—recognition of the histological spectrum allows for new insights into possible pathomechanisms. Rheumatology. 2023;62(5):2005-2014. doi:10.1093/rheumatology/keac526
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
